| API | Produktnavn | SAK NR. | Klassifisering |
| Kanagliflozin | 2-(4-fluorfenyl)-5-[(5-jod-2-metylfenyl)metyl]tiofen | 898566-17-1 | diabetes |
| Empagliflozin | (3S)-3-[4-[(5-brom-2-klorfenyl)metyl]fenoksy]tetrahydrofuran | 915095-89-5 | diabetes |
| Linagliptin | 8-brom-7-(but-2-ynyl)-3-metyl-1H-purin-2,6(3H,7H)-dion | 666816-98-4 | diabetes |
| Linagliptin | 2-(klormetyl)-4-metylkinazolin | 109113-72-6 | diabetes |
| Linagliptin | 8-brom-7-but-2-ynyl-3-metyl-1-(4-metyl-kinazolin-2-ylmetyl)-3,7-dihydro-purin-2,6-dion | 853029-57-9 | diabetes |
| Saksagliptin | (1S,3S,5S)-3-(aminokarbonyl)-2-azabicyklo[3.1.0]heksan-2-karboksylsyre-tert-butylester | 361440-67-7 | diabetes |
| Saksagliptin | (alfaS)-alfa-[[(1,1-dimetyletoksy)karbonyl]amino]-3-hydroksytricyklo[3.3.1.13,7]dekan-1-eddiksyre | 361442-00-4 | diabetes |
| Sitagliptin | 2,4,5-trifluorfenyleddiksyre | 209995-38-0 | diabetes |
| Sitagliptin | Boc-(R)-3-amino-4-(2,4,5-trifluor-fenyl)-smørsyre | 486460-00-8 | diabetes |
| Sitagliptin | 3-(trifluormetyl)-5,6,7,8-tetrahydro-[1,2,4]triazolo[4,3-a]pyrazinhydroklorid | 762240-92-6 | diabetes |
| Vildagliptin | L-prolinamid | 7531-52-4 | diabetes |
| Vildagliptin | (2S)-1-(kloracetyl)-2-pyrrolidinkarbonitril | 207557-35-5 | diabetes |
| Empagliflozin Dapagliflozin/Canagliflozin | 2,3,4,6-tetrakis-O-trimetylsilyl-D-glukonalakton | 32384-65-9 | diabetes |
| Vildagliptin | L-prolinamid | 7531-52-4 | diabetes |
| Liraglutid | Liraglutid | 204656-20-2 | diabetes |
| ABT-888 | (S)-2-metylprolin | 42856-71-3 | Anti-kreft |
| Docetaxel | 10-deacetylbaccatin III | 32981-86-5 | Anti-kreft |
| Lenvatinib | 4-klor-7-metoksykinolin-6-karboksamid | 417721-36-9 | Anti-kreft |
| Lenvatinib | 4-amino-3-klorfenolhydroklorid | 52671-64-4 | Anti-kreft |
| Acalabrutinib | (3-klorpyrazin-2-yl)metanaminhydroklorid | 939412-86-9 | Anti-kreft |
| Acalabrutinib | N-benzyloksykarbonyl-L-prolin | 1148-11-4 | Anti-kreft |
| Acalabrutinib | N-pyridin-2-yl-4-(4,4,5,5-tetrametyl-[1,3,2]dioksaborolan-2-yl)-benzamid | 1383385-64-5 | Anti-kreft |
| Acalabrutinib | 2-butynsyre | 590-93-2 | Anti-kreft |
| Nilotinib | 3-(4-metyl-1H-imidazol-1-yl)-5-(trifluormetyl)anilin | 641571-11-1 | Anti-kreft |
| Nilotinib | Difenylfosforylazid | 26386-88-9 | Anti-kreft |
| Nilotinib | 4-metyl-3-[[4-(3-pyridinyl)-2-pyrimidinyl]amino]benzosyre | 641569-94-0 | Anti-kreft |
| Nilotinib | 1-(3-pyridyl)-3-(dimetylamino)-2-propen-1-on | 55314-16-4 | Anti-kreft |
| Abirateronacetat | 17-jodoandrosta-5,16-dien-3beta-ol | 32138-69-5 | Anti-kreft |
| Abirateronacetat | 17-jodoandrosta-5,16-dien-3beta-ol-3-acetat | 114611-53-9 | Anti-kreft |
| Neratinib | 3-klor-4-(pyridin-2-ylmetoksy)anilin | 524955-09-7 | Anti-kreft |
| Neratinib | N-(4-klor-3-cyano-7-etoksy-6-kinolinyl)acetamid | 848133-76-6 | Anti-kreft |
| Neratinib | 6-amino-4-(3-klor-4-(pyridin-2-ylmetoksy)fenylamino)-7-etoksykinolin-3-karbonitril | 848139-78-6 | Anti-kreft |
| Neratinib | trans-4-dimetylaminokrotonsyrehydroklorid | 848133-35-7 | Anti-kreft |
| Palbociclib | tert-butyl 4-(6-amino-3-pyridyl)piperazin-1-karboksylat | 571188-59-5 | Anti-kreft |
| Palbociclib | 6-brom-2-klor-8-cyklopentyl-5-metylpyrido[2,3-d]pyrimidin-7(8H)-on | 1016636-76-2 | Anti-kreft |
| Ribociclib | 2-klor-7-cyklopentyl-n,n-dimetyl-7h-pyrrolo[2,3d]pyrimidin-6-karboksamid | 1211443-61-6 | Anti-kreft |
| Ribociclib | 2-klor-7-cyklopentyl-7H-pyrrolo[2,3-d]pyrimidin-6-karboksylsyre | 1211443-58-1 | Anti-kreft |
| Ceritinib/Crizotinib | 4-(4-Bromopyrazol-1-yl)piperidin-1-karboksylsyre-tert-butylester | 877399-50-3 | Anti-kreft |
| Ceritinib/Crizotinib | tert-butyl 4-[4-(4,4,5,5-tetrametyl-1,3,2-dioksaborolan-2-yl)-1H-pyrazol-1-yl]piperidin-1-karboksylat | 877399-74-1 | Anti-kreft |
| Ceritinib/Crizotinib | (S)-1-(2,6-diklor-3-fluorfenyl)etanol | 877397-65-4;42247-74-5 | Anti-kreft |
